ClinicalTrials.Veeva

Menu
M

Matrix Clinical Research | Los Angeles, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Ozanimod
Ritonavir
Linzagolix
Nirmatrelvir
Nimenrix
EVO100
MR-100A-01

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 17 total trials

A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

This is a study to demonstrate the effect of oral ozanimod as maintenance therapy in participants with moderately to severely active Crohn's Disease.

Active, not recruiting
Crohn Disease
Other: Placebo
Drug: Ozanimod

The purpose of this study is to assess the safety and immunogenicity of mRNA-1365, an mRNA vaccine targeting respiratory syncytial virus (RSV) and hu...

Enrolling
Human Metapneumovirus
Respiratory Syncytial Virus
Biological: Placebo
Biological: mRNA-1345

The primary purpose of this study is to assess the efficacy and safety of the etonogestrel (ENG) contraceptive implant during participants' fourth an...

Active, not recruiting
Contraception
Combination Product: Radiopaque Etonogestrel (ENG) Implant

The purpose of this clinical trial is to learn about how study medicine (Paxlovid, which contains nirmatrelvir and ritonavir) is changed and eliminat...

Enrolling
COVID-19
Drug: nirmatrelvir
Drug: ritonavir

This is an extension study to evaluate safety and efficacy of ozanimod in participants with moderately to severely active Crohn's Disease.

Active, not recruiting
Crohn Disease
Drug: Ozanimod

This study is a Phase III, randomized, single-blind, placebo-controlled, multi-center study to be conducted in healthy infants and toddlers aged 6 mo...

Enrolling
RSV Immunization
Biological: Diphtheria, tetanus, pertussis, Haemophilus influenzae type b and poliomyelitis vaccine
Biological: Streptococcus pneumoniae vaccine

The purpose of this study is to assess the safety and immunogenicity of a single intramuscular (IM) injection of different doses of an respiratory sy...

Enrolling
Healthy Volunteers
Human Metapneumovirus
Biological: RSV/hMPV vaccine candidate Dose B
Biological: RSV/hMPV vaccine candidate Dose A

Study of the contraceptive efficacy, cycle control, safety, and tolerability of MR-100A-01 in approxmiately 1200 women for up to 13 cycles

Active, not recruiting
Contraception
Drug: MR-100A-01

Trial sponsors

Celgene logo
Sanofi logo
BioNTech logo
Pfizer logo
Bavarian Nordic logo
E
Moderna logo
Mylan logo
N
O

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems